SPTLC1 and amyotrophic lateral sclerosis: Correspondingly, increased levels of ceramides, but not 1-deoxysphingolipid (a HSAN1 characteristic feature), are found in the sera of juvenile ALS patients with variants p.A20S, p.Y23F, p.L39del and p.F40_S41del [17].